A new study by researchers at the Icahn School of Medicine at Mount Sinai, Memorial Sloan Kettering Cancer Center, and ...

This article explores how cancer biomarkers improve early detection, guide treatments and predict outcomes to transform ...

Kazia Therapeutics (NASDAQ:KZIA) on Wednesday reported preliminary results from the first patient in its Phase 1b trial ...

The German Institute for Quality and Efficiency in Health Care (IQWiG) has examined the pros and cons of biomarker-based ...

The field of immunotherapy has transformed the landscape of cancer treatment, particularly with solid tumors, introducing newer modalities that promise more ...

Got a sore throat and the sniffles? The recent rise of rapid at-home tests has made it easier to find out if you have a ...

Indian American biomedical researcher has reported novel biomarkers for colorectal, bladder, prostate, stomach and pancreatic ...

In 2000, about 80% of clinical trials for cancer used no biomarkers at all; by 2018, more than half of oncology trials used one or more biomarkers.

Cancer biomarkers—which include inherited or acquired genetic mutations, protein alterations and other abnormalities—help oncologists determine the prognoses of newly diagnosed patients, ...

It is called HUNK (acronym of Hormonally Upregulated Neu-associated Kinase) and it is a new biomarker for gastric cancer: it ...

The researchers found that, as a biomarker of gastric cancer, SDF4 had a sensitivity of 89% and a specificity of 99%. Sensitivity shows how well the test finds the disease in sick patients ...

Monitor how likely it is for cancer to come back. In some cases, if you have a tumor, doctors will take cells from that tumor and look at biomarkers. They’ll give a recurrence risk score.